Literature DB >> 31714900

Shortened TDP43 isoforms upregulated by neuronal hyperactivity drive TDP43 pathology in ALS.

Kaitlin Weskamp1,2, Elizabeth M Tank1, Roberto Miguez1, Jonathon P McBride1,3, Nicolás B Gómez1,3, Matthew White4, Ziqiang Lin4, Carmen Moreno Gonzalez5, Andrea Serio5, Jemeen Sreedharan4, Sami J Barmada1,2,3.   

Abstract

Cortical hyperexcitability and mislocalization of the RNA-binding protein TDP43 are highly conserved features in amyotrophic lateral sclerosis (ALS). Nevertheless, the relationship between these phenomena remains poorly defined. Here, we showed that hyperexcitability recapitulates TDP43 pathology by upregulating shortened TDP43 (sTDP43) splice isoforms. These truncated isoforms accumulated in the cytoplasm and formed insoluble inclusions that sequestered full-length TDP43 via preserved N-terminal interactions. Consistent with these findings, sTDP43 overexpression was toxic to mammalian neurons, suggesting neurodegeneration arising from complementary gain- and loss-of-function mechanisms. In humans and mice, sTDP43 transcripts were enriched in vulnerable motor neurons, and we observed a striking accumulation of sTDP43 within neurons and glia of ALS patients. Collectively, these studies uncover a pathogenic role for alternative TDP43 isoforms in ALS, and implicate sTDP43 as a key contributor to the susceptibility of motor neurons in this disorder.

Entities:  

Keywords:  ALS; Cell Biology; Molecular pathology; Neuroscience; Protein misfolding

Mesh:

Substances:

Year:  2020        PMID: 31714900      PMCID: PMC7269575          DOI: 10.1172/JCI130988

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  132 in total

Review 1.  Prion-like low-complexity sequences: Key regulators of protein solubility and phase behavior.

Authors:  Titus M Franzmann; Simon Alberti
Journal:  J Biol Chem       Date:  2018-06-19       Impact factor: 5.157

2.  Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS).

Authors:  David S Howland; Jian Liu; Yijin She; Beth Goad; Nicholas J Maragakis; Benjamin Kim; Jamie Erickson; John Kulik; Lisa DeVito; George Psaltis; Louis J DeGennaro; Don W Cleveland; Jeffrey D Rothstein
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

3.  Amelioration of toxicity in neuronal models of amyotrophic lateral sclerosis by hUPF1.

Authors:  Sami J Barmada; Shulin Ju; Arpana Arjun; Anthony Batarse; Hilary C Archbold; Daniel Peisach; Xingli Li; Yuxi Zhang; Elizabeth M H Tank; Haiyan Qiu; Eric J Huang; Dagmar Ringe; Gregory A Petsko; Steven Finkbeiner
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-08       Impact factor: 11.205

4.  Identification of CRM1-dependent Nuclear Export Cargos Using Quantitative Mass Spectrometry.

Authors:  Ketan Thakar; Samir Karaca; Sarah A Port; Henning Urlaub; Ralph H Kehlenbach
Journal:  Mol Cell Proteomics       Date:  2012-12-13       Impact factor: 5.911

5.  Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis.

Authors:  Sami J Barmada; Gaia Skibinski; Erica Korb; Elizabeth J Rao; Jane Y Wu; Steven Finkbeiner
Journal:  J Neurosci       Date:  2010-01-13       Impact factor: 6.167

6.  TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia.

Authors:  Haixin Zhang; Chun-Feng Tan; Fumiaki Mori; Kunikazu Tanji; Akiyoshi Kakita; Hitoshi Takahashi; Koichi Wakabayashi
Journal:  Acta Neuropathol       Date:  2007-09-05       Impact factor: 17.088

7.  Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis.

Authors:  J D Rothstein; L J Martin; R W Kuncl
Journal:  N Engl J Med       Date:  1992-05-28       Impact factor: 91.245

8.  A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity.

Authors:  Brian S Johnson; J Michael McCaffery; Susan Lindquist; Aaron D Gitler
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-23       Impact factor: 11.205

9.  ALS Mutations Disrupt Phase Separation Mediated by α-Helical Structure in the TDP-43 Low-Complexity C-Terminal Domain.

Authors:  Alexander E Conicella; Gül H Zerze; Jeetain Mittal; Nicolas L Fawzi
Journal:  Structure       Date:  2016-08-18       Impact factor: 5.006

10.  Massive transcriptome sequencing of human spinal cord tissues provides new insights into motor neuron degeneration in ALS.

Authors:  Anna Maria D'Erchia; Angela Gallo; Caterina Manzari; Susanna Raho; David S Horner; Matteo Chiara; Alessio Valletti; Italia Aiello; Francesca Mastropasqua; Loredana Ciaccia; Franco Locatelli; Francesco Pisani; Grazia Paola Nicchia; Maria Svelto; Graziano Pesole; Ernesto Picardi
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

View more
  27 in total

Review 1.  TDP43 ribonucleoprotein granules: physiologic function to pathologic aggregates.

Authors:  Giulia Ada Corbet; Joshua R Wheeler; Roy Parker; Kaitlin Weskamp
Journal:  RNA Biol       Date:  2021-08-19       Impact factor: 4.766

2.  RNA-binding proteins direct myogenic cell fate decisions.

Authors:  Joshua R Wheeler; Oscar N Whitney; Thomas O Vogler; Eric D Nguyen; Bradley Pawlikowski; Evan Lester; Alicia Cutler; Tiffany Elston; Nicole Dalla Betta; Kevin R Parker; Kathryn E Yost; Hannes Vogel; Thomas A Rando; Howard Y Chang; Aaron M Johnson; Roy Parker; Bradley B Olwin
Journal:  Elife       Date:  2022-06-13       Impact factor: 8.713

3.  Myotubularin-related phosphatase 5 is a critical determinant of autophagy in neurons.

Authors:  Jason P Chua; Karan Bedi; Michelle T Paulsen; Mats Ljungman; Elizabeth M H Tank; Erin S Kim; Jonathon P McBride; Jennifer M Colón-Mercado; Michael E Ward; Lois S Weisman; Sami J Barmada
Journal:  Curr Biol       Date:  2022-05-16       Impact factor: 10.900

4.  A C-Terminally Truncated TDP-43 Splice Isoform Exhibits Neuronal Specific Cytoplasmic Aggregation and Contributes to TDP-43 Pathology in ALS.

Authors:  Marc Shenouda; Shangxi Xiao; Laura MacNair; Agnes Lau; Janice Robertson
Journal:  Front Neurosci       Date:  2022-06-21       Impact factor: 5.152

Review 5.  Molecular, functional, and pathological aspects of TDP-43 fragmentation.

Authors:  Deepak Chhangani; Alfonso Martín-Peña; Diego E Rincon-Limas
Journal:  iScience       Date:  2021-04-21

6.  Characterization of the human TARDBP gene promoter.

Authors:  Marco Baralle; Maurizio Romano
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

Review 7.  Multi-phaseted problems of TDP-43 in selective neuronal vulnerability in ALS.

Authors:  Kazuhide Asakawa; Hiroshi Handa; Koichi Kawakami
Journal:  Cell Mol Life Sci       Date:  2021-03-11       Impact factor: 9.261

Review 8.  It's not just a phase: function and characteristics of RNA-binding proteins in phase separation.

Authors:  Hannah J Wiedner; Jimena Giudice
Journal:  Nat Struct Mol Biol       Date:  2021-06-07       Impact factor: 18.361

9.  Human amyotrophic lateral sclerosis excitability phenotype screen: Target discovery and validation.

Authors:  Xuan Huang; Kasper C D Roet; Liying Zhang; Amy Brault; Allison P Berg; Anne B Jefferson; Jackie Klug-McLeod; Karen L Leach; Fabien Vincent; Hongying Yang; Anthony J Coyle; Lyn H Jones; Devlin Frost; Ole Wiskow; Kuchuan Chen; Rie Maeda; Alyssa Grantham; Mary K Dornon; Joseph R Klim; Marco T Siekmann; Dongyi Zhao; Seungkyu Lee; Kevin Eggan; Clifford J Woolf
Journal:  Cell Rep       Date:  2021-06-08       Impact factor: 9.423

Review 10.  Cortical Circuit Dysfunction as a Potential Driver of Amyotrophic Lateral Sclerosis.

Authors:  Aurore Brunet; Geoffrey Stuart-Lopez; Thibaut Burg; Jelena Scekic-Zahirovic; Caroline Rouaux
Journal:  Front Neurosci       Date:  2020-04-29       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.